-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on AVITA Medical, Maintains $10 Price Target

Benzinga·02/17/2026 12:56:31
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and maintains $10 price target.